(Q35031739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Background to and management of treatment-related bone loss in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Roberto Mario Scarpa

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

Alfredo Berruti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

7

Luigi Dogliotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

2

Marcello Tucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Gabriella Gorzegno

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Alberto Angeli

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

899-910

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12495366%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002512-200219120-00002

16 December 2019

exact match

0 references

cites work

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

1 reference

12 December 2020

Prediction of bone loss in postmenopausal women

1 reference

12 December 2020

Prevention of postmenopausal bone loss by tiludronate

1 reference

12 December 2020

Pathogenesis and management of cancer associated hypercalcaemia.

1 reference

12 December 2020

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy

1 reference

12 December 2020

Esophagitis associated with the use of alendronate

1 reference

12 December 2020

NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake

1 reference

12 December 2020

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

12 December 2020

Do men and women fracture bones at similar bone densities?

1 reference

12 December 2020

Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacological management of osteoporosis in postmenopausal women: a comparative review

1 reference

12 December 2020

Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer

1 reference

12 December 2020

Osteoporosis after orchiectomy for prostate cancer

1 reference

12 December 2020

Prostate cancer: population-based survival rates in central Italy

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

1 reference

12 December 2020

Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: association with prior prostate bed radiation and older age.

1 reference

12 December 2020

Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer.

1 reference

12 December 2020

Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy?

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Hip fracture incidence among the old and very old: a population-based study of 745,435 cases

1 reference

12 December 2020

Estrogens in the treatment of prostate cancer

1 reference

12 December 2020

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

1 reference

12 December 2020

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

1 reference

12 December 2020

Clinical review 134: The endocrinology of prostate cancer

1 reference

12 December 2020

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

12 December 2020

Prostate cancer, Incidence, management and outcomes

1 reference

12 December 2020

Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation.

1 reference

12 December 2020

Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists

1 reference

12 December 2020

Potential side-effects of endocrine treatment of long duration in prostate cancer

1 reference

12 December 2020

Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases.

1 reference

12 December 2020

Analysis of recent trends in prostate cancer incidence and mortality

1 reference

12 December 2020

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

1 reference

12 December 2020

Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity

1 reference

12 December 2020

Androgens and prostate cancer: biology, pathology and hormonal therapy

1 reference

12 December 2020

Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause

1 reference

12 December 2020

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

1 reference

12 December 2020

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

12 December 2020

Natural history and staging of prostate cancer

1 reference

12 December 2020

Immediate vs. delayed androgen deprivation for prostate cancer

1 reference

12 December 2020

Osteoporosis as a complication of orchiectomy in 2 elderly men with prostatic cancer

1 reference

12 December 2020

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

12 December 2020

Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities.

1 reference

12 December 2020

The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer

1 reference

12 December 2020

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

1 reference

12 December 2020

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

12 December 2020

Osteoporosis due to androgen deprivation therapy in men with prostate cancer

1 reference

12 December 2020

Patterns of prostate cancer treatment by clinical stage and age

1 reference

12 December 2020

The use of bone densitometry in clinical practice

1 reference

12 December 2020

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

1 reference

12 December 2020

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

12 December 2020

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

1 reference

12 December 2020

Androgens: basic biology and clinical implication

1 reference

12 December 2020

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension

1 reference

12 December 2020

Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

12 December 2020

Staging and prognosis of prostate cancer

1 reference

12 December 2020

Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer

1 reference

12 December 2020

Low bone mineral density in hormone-naïve men with prostate carcinoma

1 reference

12 December 2020

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

12 December 2020

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates

1 reference

12 December 2020

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

12 December 2020

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

12 December 2020